OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) 13D and 13G filings for Acorda Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-02-16 10:41 am Purchase | 2020-12-31 | 13G | Acorda Therapeutics, Inc. ACOR | OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 266,162 9.990% | 266,162 (New Position) | Filing |